The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49

Author： Norman Richard Evans D. Easton Douglas Young Kenneth

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.8, Iss.2, 2007-06, pp. : 137-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast cancer in BRCA mutation carriers: breast-conserving therapy or bilateral mastectomy?

By Murphy James O Sacchini Virgilio S

Clinical Practice, Vol. 10, Iss. 6, 2013-11 ,pp. : 751-764

Future Medicine

Access to resources Recommend Favorite

Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1136-1146

John Wiley & Sons Inc

Access to resources Recommend Favorite

Skin cancer risk in BRCA1/2 mutation carriers

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 6, 2015-06 ,pp. : 1498-1506

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRCA1 Germline Mutation in a Woman with Metaplastic Squamous Cell Breast Cancer

Oncology Research and Treatment, Vol. 30, Iss. 6, 2007-05 ,pp. : 316-318

Karger

Access to resources Recommend Favorite

Comments on “Radiation induced breast cancer risk in BRCA mutation carriers from low-dose radiological exposures: a systematic review”

By Bevelacqua J.J. Welsh J. Mortazavi S.M.J. Doss M.

Radioprotection, Vol. 53, Iss. 1, 2018-03 ,pp. : 67-68

Edp Sciences

Access to resources Recommend Favorite